Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Future Oncology (London, England)|December 13, 2019
Atezolizumab for use in PD-L1-positive unresectable, locally advanced or metastatic triple-negative breast cancerAthanasios Mavratzas, Julia Seitz, Katharina Smetanay, et al.Anticancer Research|July 31, 2013
Nab-Paclitaxel monotherapy as a treatment of patients with metastatic breast cancer in routine clinical practiceJulia Aigner, Frederik Marmé, Katharina Smetanay, et al.Targeted Oncology|June 10, 2020
Immune Checkpoint Blockade in Patients with Triple-Negative Breast CancerLaura L Michel, Alexandra von Au, Athanasios Mavratzas, et al.Annals of Surgical Oncology|February 8, 2013
Omission of axillary dissection according to ACOSOG Z0011: impact on adjuvant treatment recommendationsJulia Aigner, Katharina Smetanay, Holger Hof, et al.Archives of Gynecology and Obstetrics|August 11, 2016
Exam preparation course in obstetrics and gynecology for the German Medical State Examination: proof of concept and implications for the recruitment of future residentsFabian Riedel, Carlo Fremd, Patrik Tabatabai, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 23, 2025
Use of bevacizumab for patients with International Federation of Gynecology and Obstetrics stage IIIB to IV epithelial ovarian cancer undergoing primary debulking surgery and its association with oncologic outcomes: a Cancer Registry studyAndré Pfob, Irina Surovtsova, Daria B Kokh, et al.Anticancer Research|November 5, 2014
Efficacy of nab-paclitaxel does not seem to be associated with SPARC expression in metastatic breast cancerAndreas Schneeweiss, Julia Seitz, Katharina Smetanay, et al.Technology in Cancer Research & Treatment|August 11, 2022
Age-Dependent Hematologic Toxicity Profiles and Prognostic Serologic Markers in Postoperative Radiochemotherapy Treatment for Uterine Cervical CancerEva Meixner, Line Hoeltgen, Philipp Hoegen, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 1, 2021
Stereotactic radiosurgery for brain metastases from pelvic gynecological malignancies: oncologic outcomes, validation of prognostic scores, and dosimetric evaluationEva Meixner, Tanja Eichkorn, Sinem Erdem, et al.Cancers|May 11, 2024
The Safety and Efficacy of the Combination of Sacituzumab Govitecan and Palliative Radiotherapy-A Retrospective Multi-Center Cohort StudyDavid Krug, Joke Tio, Ali Abaci, et al.Pageof 3